Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Haruki Imamura
The Elevation of Cardio-Ankle Vascular Index in a Patient With Malignant Lymphoma Treated With a Combination Therapy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone
Journal of Clinical Medicine Research
Inverse Relationship of Cardioankle Vascular Index With BMI in Healthy Japanese Subjects: A Cross-Sectional Study
Vascular Health and Risk Management
Related publications
CD5-positive Diffuse Large B-Cell Lymphoma Showing Prominent Intra-Sinusoidal Infiltration in the Bone Marrow, Successfully Treated With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone in Combination With Rituximab
Tenri Medical Bulletin
Accept: A Phase Ib/Ii Combination of Acalabrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone (R-Chop) for Patients With Diffuse Large B-Cell Lymphoma (Dlbcl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A Case of Malignant Pheochromocytoma Treated With a Combination of Cyclophosphamide, Vincristine, and Dacarbazine (CVD). A Review of the Japanese Literature of Malignant Pheochromocytoma Treated With a Combination of CVD
Folia Endocrinologica Japonica
A Phase II Study of Bortezomib Added to Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Indolent Non-Hodgkin's Lymphoma
British Journal of Haematology
Hematology
A Phase II Study of Ibrutinib in Combination With Rituximab-Cyclophosphamide-Doxorubicin Hydrochloride-Vincristine Sulfate-Prednisone Therapy in Epstein-Barr Virus-Positive, Diffuse Large B Cell Lymphoma (54179060LYM2003: IVORY Study): Results of the Final Analysis
Annals of Hematology
Medicine
Hematology
Fourteen-Day Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone (R-Chop-14): Use It Right or Do Not Use It at All
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
Treatment of Non-Small Cell Carcinoma of the Lung by a Combination Chemotherapy With Cyclophosphamide, Vincristine, and Methotrexate, or With Adriamycin, Cyclophosphamide, Vincristine, and Methotrexate.
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
Kidney International Reports
Nephrology
Impact of Body Mass Index on Incidence of Febrile Neutropenia and Treatment-Related Mortality in United States Veterans With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone
British Journal of Haematology
Hematology
